Sarcopenia
Welcome,         Profile    Billing    Logout  
 46 Companies   12 Products   12 Products   17 Mechanisms of Action   756 Trials   22406 News 


«12...385386387388389390391392393394395...401402»
  • ||||||||||  Trial primary completion date:  UNITS: The Urinary Incontinence Treatment Study (clinicaltrials.gov) -  Feb 5, 2019   
    P=N/A,  N=100, Recruiting, 
    Trial primary completion date: Jan 2019 --> Jan 2020
  • ||||||||||  Trial completion, Trial completion date, Trial primary completion date:  Improving Rehabilitation In Sarcopenia (IRIS) (clinicaltrials.gov) -  Jan 31, 2019   
    P=N/A,  N=140, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed | Trial completion date: Jul 2019 --> Dec 2018 | Trial primary completion date: May 2019 --> Dec 2018
  • ||||||||||  Avastin (bevacizumab) / Roche
    PK/PD data, Journal:  The impact of skeletal muscle on the pharmacokinetics and toxicity of 5-fluorouracil in colorectal cancer. (Pubmed Central) -  Jan 29, 2019   
    Recruiting --> Completed | Trial completion date: Jul 2019 --> Dec 2018 | Trial primary completion date: May 2019 --> Dec 2018 Although our results did not confirm the impact of low skeletal muscle on PKs of 5FU, further research exploring the impact of body composition on chemotherapy PKs and related toxicities is warranted with the potential for alternative dosing strategies in sarcopenic patients to reduce unnecessary toxicities while maintaining efficacy.
  • ||||||||||  Trial completion date, Trial primary completion date:  Microbiome and Sarcopenia in Patients With Liver Cirrhosis (clinicaltrials.gov) -  Jan 24, 2019   
    P=N/A,  N=120, Recruiting, 
    Although our results did not confirm the impact of low skeletal muscle on PKs of 5FU, further research exploring the impact of body composition on chemotherapy PKs and related toxicities is warranted with the potential for alternative dosing strategies in sarcopenic patients to reduce unnecessary toxicities while maintaining efficacy. Trial completion date: Apr 2019 --> Dec 2019 | Trial primary completion date: Dec 2018 --> Jul 2019
  • ||||||||||  Enrollment open, Trial initiation date:  Dietary Nitrate and Muscle Power With Aging (clinicaltrials.gov) -  Jan 18, 2019   
    P1,  N=20, Recruiting, 
    Those with sarcopenia and PAD demonstrate decreased mobility function. Not yet recruiting --> Recruiting | Initiation date: Sep 2018 --> Jan 2019
  • ||||||||||  NN1213 / Novo Nordisk
    Trial primary completion date:  Exercise Intervention in Liver Transplant Patients (clinicaltrials.gov) -  Jan 15, 2019   
    P=N/A,  N=500, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Dec 2018 --> Dec 2019
  • ||||||||||  NN1213 / Novo Nordisk
    Biomarker, Trial completion date:  A Prospective Study Of Biomarkers Of Skeletal Muscle Atrophy (clinicaltrials.gov) -  Jan 11, 2019   
    P=N/A,  N=30, Active, not recruiting, 
    Trial primary completion date: Dec 2018 --> Dec 2019 Trial completion date: Dec 2018 --> Mar 2019
  • ||||||||||  Enrollment open, Trial primary completion date, Surgery:  FrOGS: Frailty and Sarcopenia Outcomes in Emergency General Surgery (clinicaltrials.gov) -  Jan 10, 2019   
    P=N/A,  N=294, Recruiting, 
    N=24 --> 34 Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2018 --> Mar 2019
  • ||||||||||  Enrollment open:  Electrical Stimulation of Human Myocytes in Microgravity (clinicaltrials.gov) -  Jan 4, 2019   
    P=N/A,  N=75, Recruiting, 
    Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2018 --> Mar 2019 Not yet recruiting --> Recruiting
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Trial completion date:  Measurement of Sarcopenia at Post-stroke Rehabilitation Outcome (clinicaltrials.gov) -  Jan 3, 2019   
    P=N/A,  N=70, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed | Trial completion date: Sep 2017 --> Dec 2018
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion date, Trial primary completion date:  MM-DC: Estimation of Muscle Mass in Older Adults Using Deuterated Creatine (clinicaltrials.gov) -  Dec 21, 2018   
    P=N/A,  N=62, Recruiting, 
    Recruiting --> Completed | Trial completion date: Sep 2017 --> Dec 2018 Trial completion date: Jul 2018 --> Dec 2018 | Trial primary completion date: Jul 2018 --> Dec 2018
  • ||||||||||  NN1213 / Novo Nordisk
    Trial primary completion date:  Counteracting Age-related Loss of Skeletal Muscle Mass (clinicaltrials.gov) -  Dec 13, 2018   
    P=N/A,  N=205, Recruiting, 
    Trial completion date: Jul 2018 --> Dec 2018 | Trial primary completion date: Jul 2018 --> Dec 2018 Trial primary completion date: Jul 2018 --> Jan 2019
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion date, Trial primary completion date:  Counteracting Age-related Loss of Skeletal Muscle Mass (CALM) (clinicaltrials.gov) -  Dec 13, 2018   
    P=N/A,  N=66, Recruiting, 
    Trial primary completion date: Jul 2018 --> Jan 2019 Trial completion date: Jul 2018 --> Feb 2019 | Trial primary completion date: Jul 2018 --> Jan 2019
  • ||||||||||  bimagrumab (BYM338) / Eli Lilly
    Trial completion, Trial completion date, Trial primary completion date:  Dose Range Finding Study of Bimagrumab in Sarcopenia (clinicaltrials.gov) -  Dec 6, 2018   
    P2,  N=211, Completed, 
    Recruiting --> Active, not recruiting | Trial completion date: Aug 2019 --> Dec 2018 Recruiting --> Completed | Trial completion date: Oct 2018 --> Jun 2018 | Trial primary completion date: Oct 2018 --> Jun 2018
  • ||||||||||  Niagen (nicotinamide riboside) / ChromaDex
    Enrollment open:  CoNR: Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease (clinicaltrials.gov) -  Dec 6, 2018   
    P2,  N=30, Recruiting, 
    Recruiting --> Completed | Trial completion date: Oct 2018 --> Jun 2018 | Trial primary completion date: Oct 2018 --> Jun 2018 Not yet recruiting --> Recruiting
  • ||||||||||  Enrollment closed, Trial completion date, Trial primary completion date:  Exercise Effects on Sarco-Osteopenia in Older Men (clinicaltrials.gov) -  Nov 14, 2018   
    P=N/A,  N=42, Active, not recruiting, 
    Trial completion date: Jan 2018 --> Jan 2019 | Trial primary completion date: Jan 2018 --> Dec 2018 Recruiting --> Active, not recruiting | Trial completion date: Mar 2021 --> Dec 2020 | Trial primary completion date: Nov 2020 --> Jul 2020
  • ||||||||||  Trial completion date, Trial primary completion date:  The QUALITY Vets Project: Muscle Quality and Kidney Disease (clinicaltrials.gov) -  Nov 9, 2018   
    P=N/A,  N=75, Recruiting, 
    Recruiting --> Active, not recruiting | Trial completion date: Mar 2021 --> Dec 2020 | Trial primary completion date: Nov 2020 --> Jul 2020 Trial completion date: Mar 2019 --> Mar 2020 | Trial primary completion date: Oct 2018 --> Oct 2019
  • ||||||||||  Trial completion date:  Sarcopenia and Visceral Obesity in Esophageal and Gastric Cancer (clinicaltrials.gov) -  Nov 8, 2018   
    P=N/A,  N=500, Active, not recruiting, 
    Trial completion date: Mar 2019 --> Mar 2020 | Trial primary completion date: Oct 2018 --> Oct 2019 Trial completion date: Jan 2018 --> Jan 2019
  • ||||||||||  Trial completion date, Trial primary completion date:  Improving Muscle Strength, Mass and Physical Function in Older Adults (clinicaltrials.gov) -  Oct 26, 2018   
    P=N/A,  N=210, Enrolling by invitation, 
    Trial completion date: Jan 2018 --> Jan 2019 Trial completion date: Nov 2018 --> Nov 2019 | Trial primary completion date: Nov 2018 --> Nov 2019
  • ||||||||||  Niagen (nicotinamide riboside) / ChromaDex
    Trial initiation date:  CoNR: Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease (clinicaltrials.gov) -  Oct 19, 2018   
    P2,  N=30, Not yet recruiting, 
    Trial completion date: Nov 2018 --> Nov 2019 | Trial primary completion date: Nov 2018 --> Nov 2019 Initiation date: Aug 2018 --> Nov 2018
  • ||||||||||  Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  SPRI: Supplemental Egg Protein Intervention In Older Adults (clinicaltrials.gov) -  Oct 17, 2018   
    P=N/A,  N=51, Completed, 
    Trial completion date: Jan 2018 --> Jan 2020 | Trial primary completion date: Oct 2017 --> Jul 2019 Enrolling by invitation --> Completed | N=100 --> 51 | Trial completion date: Jun 2018 --> Aug 2018 | Trial primary completion date: Jun 2018 --> Aug 2018
  • ||||||||||  Trial completion date, Trial primary completion date:  Use of the Sit-To-Stand Task as a Screening Tool for Sarcopenia The (clinicaltrials.gov) -  Oct 10, 2018   
    P=N/A,  N=40, Recruiting, 
    Enrolling by invitation --> Completed | N=100 --> 51 | Trial completion date: Jun 2018 --> Aug 2018 | Trial primary completion date: Jun 2018 --> Aug 2018 Trial completion date: Aug 2018 --> Mar 2019 | Trial primary completion date: Jun 2018 --> Jan 2019
  • ||||||||||  NN1213 / Novo Nordisk
    Enrollment closed, Trial primary completion date:  MUSFAT: Muscle Loss and Fatigue as a Consequence of Radiotherapy (clinicaltrials.gov) -  Oct 5, 2018   
    P=N/A,  N=20, Active, not recruiting, 
    Trial completion date: Aug 2018 --> Mar 2019 | Trial primary completion date: Jun 2018 --> Jan 2019 Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Oct 2017 --> Oct 2019